{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:41:05Z","timestamp":1715575265436},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2050-6511-15-69","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:01:33Z","timestamp":1417651293000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution"],"prefix":"10.1186","volume":"15","author":[{"given":"Ashraf G","family":"Madian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoli A","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navin","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"356_CR1","volume-title":"Approved Drug Products With Therapeutic Equivalence Evaluations (Orange Book)","author":"US Department of Health and Human Service FaDA","year":"2012","unstructured":"US Department of Health and Human Service FaDA: Approved Drug Products With Therapeutic Equivalence Evaluations (Orange Book). 2012, [http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/UCM071436.pdf] accessed 2013 Jan10, 32","edition":"32"},{"key":"356_CR2","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1016\/j.transproceed.2012.08.003","volume":"44","author":"F Bora","year":"2012","unstructured":"Bora F, Aliosmanoglu I, Kocak H, Dinckan A, Uslu HB, Gunseren F, Suleymanlar G: Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. Transplant Proc. 2012, 44: 3029-3032. 10.1016\/j.transproceed.2012.08.003.","journal-title":"Transplant Proc"},{"key":"356_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00228-012-1296-4","volume":"69","author":"N Han","year":"2013","unstructured":"Han N, Yun H-Y, Hong J-Y, Ji E, Hong SH, Kim YS, Ha J, Shin WG, Oh JM: Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. Eur J Clin Pharmacol. 2013, 69: 53-63.","journal-title":"Eur J Clin Pharmacol"},{"key":"356_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1399-3046.2010.01393.x","volume":"14","author":"HA Abdulnour","year":"2010","unstructured":"Abdulnour HA, Araya CE, Dharnidharka VR: Comparison of generic tacrolimus and Prograf\u00ae drug levels in a pediatric kidney transplant program: brief communication. Pediatr Transplant. 2010, 14: 1007-1011. 10.1111\/j.1399-3046.2010.01393.x.","journal-title":"Pediatr Transplant"},{"key":"356_CR5","first-page":"S1","volume-title":"Kidney Int Suppl","author":"U Christians","year":"2010","unstructured":"Christians U, Klawitter J, Clavijo CF: Bioequivalence testing of immunosuppressants: concepts and misconceptions. Kidney Int Suppl. 2010, S1-S7."},{"key":"356_CR6","volume-title":"FDA Approved Drug Products","author":"U.S. Food and Drug Administration","year":"2013","unstructured":"U.S. Food and Drug Administration: FDA Approved Drug Products. 2013, [http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda] accessed 2013 Jan 16"},{"key":"356_CR7","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/TP.0b013e318256dd13","volume":"93","author":"A Connor","year":"2012","unstructured":"Connor A, Prowse A, Macphee I, Rowe PA: Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure. Transplantation. 2012, 93: e45-e46. 10.1097\/TP.0b013e318256dd13.","journal-title":"Transplantation"},{"key":"356_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijantimicag.2006.01.003","volume":"27","author":"D Leveque","year":"2006","unstructured":"Leveque D, Nivoix Y, Jehl F, Herbrecht R: Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents. 2006, 27: 274-284. 10.1016\/j.ijantimicag.2006.01.003.","journal-title":"Int J Antimicrob Agents"},{"key":"356_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.TP.0000072339.10649.9C","volume":"76","author":"MA Chisholm","year":"2003","unstructured":"Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT: Coadministration of tacrolimus with anti-acid drugs. Transplantation. 2003, 76: 665-666. 10.1097\/01.TP.0000072339.10649.9C.","journal-title":"Transplantation"},{"key":"356_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1742-7843.2012.00904.x","volume":"111","author":"I-W Kim","year":"2012","unstructured":"Kim I-W, Noh H, Ji E, Han N, Hong SH, Ha J, Burckart GJ, Oh JM: Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. Basic Clin Pharmacol Toxicol. 2012, 111: 217-223.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"356_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.transproceed.2009.03.061","volume":"41","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Huh KH, Han DJ, Moon IS, Kim SJ, Kim YL, Kim HC, Lee S, Kang CM, Cho BH, Kim YS: A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation. Transplant Proc. 2009, 41: 1671-1674. 10.1016\/j.transproceed.2009.03.061.","journal-title":"Transplant Proc"},{"key":"356_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/TP.0b013e31822a79ad","volume":"92","author":"LM McDevitt-Potter","year":"2011","unstructured":"McDevitt-Potter LM, Sadaka B, Tichy EM, Rogers CC, Gabardi S: A multicenter experience with generic tacrolimus conversion. Transplantation. 2011, 92: 653-657. 10.1097\/TP.0b013e31822a79ad.","journal-title":"Transplantation"},{"key":"356_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/phar.1130","volume":"32","author":"MM Spence","year":"2012","unstructured":"Spence MM, Nguyen LM, Hui RL, Chan J: Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system. Pharmacotherapy. 2012, 32: 981-987. 10.1002\/phar.1130.","journal-title":"Pharmacotherapy"},{"key":"356_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5754\/hge11472","volume":"59","author":"Y-D Yu","year":"2012","unstructured":"Yu Y-D, Lee S-G, Joh J-W, Kwon CH, Kim DG, Suh KS, Lee NJ, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH: Results of a phase 4 trial of Tacrobell\u00ae in liver transplantation patients: a multicenter study in South Korea. Hepatogastroenterology. 2012, 59: 357-363.","journal-title":"Hepatogastroenterology"},{"key":"356_CR15","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1111\/j.1600-6143.2012.04174.x","volume":"12","author":"RR Alloway","year":"2012","unstructured":"Alloway RR, Sadaka B, Trofe-Clark J, Wiland A, Bloom RD: A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. Am J Transplant. 2012, 12: 2825-2831. 10.1111\/j.1600-6143.2012.04174.x.","journal-title":"Am J Transplant"},{"key":"356_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ckj\/sfu015","volume":"7","author":"S Rosenborg","year":"2014","unstructured":"Rosenborg S, Nordstr\u00f6m A, Almquist T, Wennberg L, B\u00e1r\u00e1ny P: Systematic conversion to generic tacrolimus in stable kidney transplant recipients. Clin Kidney J. 2014, 7: 151-155. 10.1093\/ckj\/sfu015.","journal-title":"Clin Kidney J"},{"key":"356_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1592\/phco.31.11.1111","volume":"31","author":"CR Ensor","year":"2011","unstructured":"Ensor CR, Trofe-Clark J, Gabardi S, McDevitt-Potter LM, Shullo MA: Generic maintenance immunosuppression in solid organ transplant recipients. Pharmacotherapy. 2011, 31: 1111-1129. 10.1592\/phco.31.11.1111.","journal-title":"Pharmacotherapy"},{"key":"356_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1046\/j.1600-6143.2003.00212.x","volume":"3","author":"R Alloway Rita","year":"2003","unstructured":"Alloway Rita R, Isaacs R, Lake K, Hoyer P, First R, Helderman H, Bunnapradist S, Leichtman A, Bennett MW, Tejani A, Takemoto SK: Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Am J Transplant. 2003, 3: 1211-1215. 10.1046\/j.1600-6143.2003.00212.x.","journal-title":"Am J Transplant"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2050-6511-15-69\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2050-6511-15-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:07:41Z","timestamp":1630566461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/2050-6511-15-69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/2050-6511-15-69","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"25 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"69"}}